Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | SLNSilence Therapeutics plcFY2025 · Dec |
|---|---|
| Revenue | $559.00K |
| Revenue, yoy | −98.7% |
| Net income | $88.61M |
| Net income, yoy | −95.6% |
| Net margin | -15,851.9% |
| Free cash flow | $62.33M |
| FCF margin | -11,149.6% |
| EPS, diluted | $0.63 |
Add another company.